Retraction
Open Access | 
10.1172/jci.insight.146654
Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
Kate E. Bailey, Guy A. MacGowan, Simon Tual-Chalot, Lauren Phillips, Timothy J. Mohun, Deborah J. Henderson, Helen M. Arthur, Simon D. Bamforth, and Helen M. Phillips
Find articles by Bailey, K. in: JCI | PubMed | Google Scholar
Find articles by MacGowan, G. in: JCI | PubMed | Google Scholar
Find articles by Tual-Chalot, S. in: JCI | PubMed | Google Scholar
Find articles by Phillips, L. in: JCI | PubMed | Google Scholar
Find articles by Mohun, T. in: JCI | PubMed | Google Scholar
Find articles by Henderson, D. in: JCI | PubMed | Google Scholar
Find articles by Arthur, H. in: JCI | PubMed | Google Scholar
Find articles by Bamforth, S. in: JCI | PubMed | Google Scholar
Find articles by Phillips, H. in: JCI | PubMed | Google Scholar
Published December 17, 2020 - More info
JCI Insight. 2020;5(24):e146654. https://doi.org/10.1172/jci.insight.146654.
© 2020 cardiomyopathy et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Related article:
Abstract
Sarcomeric disarray is a hallmark of gene mutations in patients with hypertrophic cardiomyopathy (HCM). However, it is unknown when detrimental sarcomeric changes first occur and whether they originate in the developing embryonic heart. Furthermore, Rho kinase (ROCK) is a serine/threonine protein kinase that is critical for regulating the function of several sarcomeric proteins, and therefore, our aim was to determine whether disruption of ROCK signaling during the earliest stages of heart development would disrupt the integrity of sarcomeres, altering heart development and function. Using a mouse model in which the function of ROCK is specifically disrupted in embryonic cardiomyocytes, we demonstrate a progressive cardiomyopathy that first appeared as sarcomeric disarray during cardiogenesis. This led to abnormalities in the structure of the embryonic ventricular wall and compensatory cardiomyocyte hypertrophy during fetal development. This sarcomeric disruption and hypertrophy persisted throughout adult life, triggering left ventricular concentric hypertrophy with systolic dysfunction, and reactivation of fetal gene expression and cardiac fibrosis, all typical features of HCM. Taken together, our findings establish a mechanism for the developmental origin of the sarcomeric phenotype of HCM and suggest that variants in the ROCK genes or disruption of ROCK signaling could, in part, contribute to its pathogenesis.
Authors
Kate E. Bailey, Guy A. MacGowan, Simon Tual-Chalot, Lauren Phillips, Timothy J. Mohun, Deborah J. Henderson, Helen M. Arthur, Simon D. Bamforth, Helen M. Phillips
Original citation: JCI Insight. 2019;4(8):e125172. https://doi.org/10.1172/jci.insight.125172
Citation for this retraction: JCI Insight. 2020;5(24):e146654. https://doi.org/10.1172/jci.insight.146654
Newcastle University recently notified JCI Insight of data manipulation in this article. In accordance with the institutional recommendation and at the request of the corresponding author, JCI Insight is retracting this article.
